By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Repros Therapeutics Inc. 

2408 Timberloch Place
Suite B-7
The Woodlands  Texas  77380  U.S.A.
Phone: 281-719-3400 Fax: 281-719-3446


SEARCH JOBS








Company News
Repros Therapeutics Inc. (RPRX) Submits New Drug Application To FDA For Androxal® 2/2/2015 7:47:27 AM
Repros Therapeutics Inc. (RPRX) Initiates Two Phase 2B Uterine Fibroid Studies 12/30/2014 7:32:20 AM
Repros Therapeutics Inc. (RPRX) Updates Androxal® Global Regulatory Status 12/30/2014 7:30:37 AM
Repros Therapeutics Inc. (RPRX) Confirmed As Sole Owner 12/29/2014 9:46:12 AM
Repros Therapeutics Inc. (RPRX) Reports Third Quarter 2014 Financial Results 11/10/2014 8:02:14 AM
Repros Therapeutics Inc. (RPRX) Holds Constructive Meeting With FDA Regarding Androxal® NDA Filing 11/7/2014 7:36:52 AM
Repros Therapeutics Inc. (RPRX) To Webcast Investor And Analyst Day On October 31st 10/28/2014 7:06:42 AM
Repros Therapeutics Inc. (RPRX) Release: Results From Long-Term Study Of Androxal® Exhibit Positive Safety Profile 10/22/2014 7:00:11 AM
Repros Therapeutics Inc. (RPRX) Shares Tank On Drug Application Setback 10/17/2014 7:15:39 AM
Repros Therapeutics Inc. (RPRX) Release: Androxal® Second Pivotal Study Achieves Superiority In Top Line Analysis For Both Co-Primary Endpoints Versus Marketed Topical Gel In The Treatment Of Secondary Hypogonadism 9/26/2014 7:16:45 AM
12345678910...
//-->